TGF-Beta Inihibitor-loaded Polyelectrolyte Multilayers Capsules for Sustained Targeting of Hepatocarcinoma Cells

E-ISSN： 1873-4286|18|27|4155-4164

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.27, 2012-09, pp. : 4155-4164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TGF-beta Signaling in Cancer Treatment

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2934-2947

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet-Rich Plasma Induces Mixed Osteogenic/Osteoclastogenic Phenotype in Osteosarcoma SaOS-2 Cells: Role of TGF-Beta

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 2, 2014-02 ,pp. : 120-126

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-Beta: a Master Switch in Tumor Immunity

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4126-4134

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-Beta Signaling Manipulation as Potential Therapy for IBD

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1400-1404

Bentham Science Publishers

Access to resources Recommend Favorite

Tramadol Sustained-Release Capsules

By Keating Gillian M.

Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. : 223-230

Adis International

Access to resources Recommend Favorite